r.oyelaran

TL2 · Córdoba

Contributes reviews on supplier material. Based in Córdoba.

Joined 30 November 2024 · last posted 5d

80 posts, newest first. Showing up to 150.

Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #34 · Compounds › Semaglutide · 23 Jul 2026 · 7 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #71 · Start Here › Welcome · 22 Jul 2026 · 12 likes Where the Reading order discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
Pancreatitis history and the risk calculus Replied, post #30 · Safety › Contraindications · 18 Jul 2026 · 23 likes Where I part company with post #28, and it is a narrow parting. Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia,…
Seven-day rolling means and why weekly readings mislead Replied, post #41 · Outcomes › Progress reports · 16 Jul 2026 · 3 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops.
How shortages have affected compounding permissions Replied, post #41 · Access › Shortages · 15 Jul 2026 · 6 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
Historical amylin analogues and what happened to them Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2026 · 19 likes Post #28 and I disagree about the size of the effect, not about the direction. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #27 · Practice › Dosing & titration · 30 Jun 2026 · 6 likes Bookmarking this. I will come back when I have something worth adding.
Why the timeline is on the right and not the left — what changed since Replied, post #61 · Meta › Site feedback · 24 Jun 2026 · 0 likes Post #57 put the caveat in the right place and I want to underline it. Where the timeline discussion usually stalls is that nobody wants to say "I do not know" and…
I have no scientific background — can I still follow the analytics categories? Replied, post #25 · Start Here › Welcome · 23 Jun 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
GLP-1 receptor distribution: central and peripheral Replied, post #75 · Pharmacology › Receptor biology · 23 Jun 2026 · 32 likes Post #71 put the caveat in the right place and I want to underline it. The area postrema sits outside the blood-brain barrier and is where a great deal of the nausea…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #44 · Compounds › Secretagogues & GH axis · 21 Jun 2026 · 23 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #112 · Practice › Reconstitution · 16 Jun 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #63 · Meta › Announcements · 12 Jun 2026 · 19 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning. On reflection I would soften that slightly.
Angle of injection and whether 90 degrees is always right — the long version Replied, post #19 · Practice › Administration · 7 Jun 2026 · 10 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #40 · Analytics › Home & field testing · 1 Jun 2026 · 30 likes I have been on both sides of the Reflectance and photometric devices argument in this category within eighteen months, which should tell you how strong the evidence for…
Packaging that arrived damaged: documenting it properly Replied, post #15 · Sourcing › Logistics · 26 May 2026 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #83 · Outcomes › Body composition · 26 May 2026 · 0 likes The arithmetic in post #82 is right; the assumption feeding it is the part to check. Resting metabolic rate: body composition affects metabolic rate. As fat mass…
EU-wide position versus national implementation — what changed since Replied, post #27 · Regional › European Union · 17 May 2026 · 0 likes The honest answer on eu-wide position versus national implementation is that it depends, and the useful part is the list of what it depends on. Four items, in rough…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #32 · Clinical › Bloodwork · 14 May 2026 · 10 likes Two people in this thread mean different things by Liver enzymes drifting and are disagreeing about the definition while believing they are disagreeing about the facts.…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #9 · Compounds › Semaglutide · 11 May 2026 · 7 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #22 · Analytics › HPLC & UHPLC · 5 May 2026 · 12 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
Moderation log format change Replied, post #50 · Meta › Announcements · 5 May 2026 · 16 likes Worth separating two things that post #46 runs together. Supportive, with one reservation worth stating in public: the change makes a common case slightly slower in…
Follow-up: Reconciling a label claim with a content assay Replied, post #18 · Analytics › COA interpretation · 4 May 2026 · 12 likes I keep a log for Reconciling a label claim specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
Request: show the solution author in the topic list — what changed since Replied, post #4 · Meta › Feature requests · 30 Apr 2026 · 0 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #17 · Compounds › Repair & healing peptides · 27 Apr 2026 · 11 likes Mechanistic accounts in this area run well ahead of the outcome data. Angiogenesis and cell migration effects in a dish are real observations and are a long way from a…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #121 · Clinical › Special populations · 23 Apr 2026 · 2 likes Post #120 put the caveat in the right place and I want to underline it. Where I have landed on pregnancy and pregnancy planning, having got it wrong once in public: the…
Follow-up: State-level differences that actually matter Replied, post #5 · Regional › North America · 3 Apr 2026 · 8 likes Something worth flagging about State-level differences: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #62 · Lounge › Introductions · 14 Mar 2026 · 1 like Welcome. Nobody will mind you asking something basic. The people most likely to answer are the ones who remember not knowing it. I would want to see it done twice…
Guidelines revision: what changed and why — one year on Replied, post #77 · Meta › Announcements · 2 Mar 2026 · 30 likes Answering the question post #73 raises rather than the one it answers. Worth stating the null on Guidelines revision before we explain it: the observation may be…
Trifluoroacetate content and its consequences Replied, post #98 · Analytics › Impurities & related substances · 7 Feb 2026 · 2 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #15 · Analytics › COA interpretation · 3 Feb 2026 · 0 likes Taking post #12 at face value and following it one step further. Two claims get bundled together under Reused chromatograms across lots and they need separating. The…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #11 · Outcomes › Body composition · 28 Jan 2026 · 5 likes On post #9 — agreed on the reasoning, with one qualification. Neither method is capable of detecting the month-to-month changes that people report detecting month to…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #7 · Evidence › Journal club · 5 Jan 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
Distinguishing expected GI effects from something that needs urgent attention Replied, post #4 · Practice › Side effects · 30 Dec 2025 · 0 likes Adding the measurement that the opening post says would settle it. Injection-site reactions are usually local, brief and unremarkable. A reaction spreading over a day,…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #73 · Compounds › Semaglutide · 20 Dec 2025 · 18 likes Adding the measurement that post #70 says would settle it. Adding a reference point for semaglutide half-life. Mine is a single case, collected without controls, and I…
Reading an interaction checker output critically Replied, post #70 · Practice › Interactions · 19 Dec 2025 · 1 like Worth separating two things that post #66 runs together. Genuine question rather than a rhetorical one: has anyone here actually observed reading an interaction checker…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #68 · Compounds › Tirzepatide · 10 Dec 2025 · 0 likes Post #66 and I disagree about the size of the effect, not about the direction. Comparisons between the tirzepatide and semaglutide programmes across trials rather than…
Heterogeneity as information rather than as a nuisance Replied, post #9 · Evidence › Meta-analyses · 27 Nov 2025 · 0 likes The arithmetic in post #8 is right; the assumption feeding it is the part to check. Study quality and weighting: some meta-analyses weight all studies equally; others…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #14 · Research Methods › N-of-1 designs · 24 Oct 2025 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. A rolling mean over several days is far more informative than any single reading for anything…
New subcategory: rationale and scope Replied, post #37 · Meta › Announcements · 16 Oct 2025 · 1 like Worth separating two things that post #33 runs together. Checked the new subcategory claim against the primary source this morning. It survives, with a narrower scope…
Availability by country, dated, with primary sources Replied, post #19 · Access › International · 13 Oct 2025 · 6 likes The number people quote for availability is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative…
Sleep quality changes during weight loss — what changed since Replied, post #13 · Wellbeing › Sleep · 30 Sep 2025 · 7 likes Taking post #10 at face value and following it one step further. Sleep quality versus quantity: some people report changes to sleep duration; others report changes to…
Which panel is worth repeating and which is worth ignoring Replied, post #124 · Clinical › Bloodwork · 29 Sep 2025 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Discussing something you have already been doing Replied, post #6 · marked as the solution · Clinical › Prescriber conversations · 18 Sep 2025 · 31 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. The conclusion is tentative;…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #81 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes That reframing is the whole thing. The facts I already had.
Confounding by indication, explained with a concrete example Replied, post #19 · Evidence › Study critique · 2 Sep 2025 · 12 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper. Marking that as an opinion…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #9 · Lounge › Off topic · 28 Aug 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
Pages past their review date, listed Replied, post #21 · Meta › Wiki maintenance · 23 Aug 2025 · 2 likes Worth separating pages past as a question about the compound from pages past as a question about the documentation. They get answered by different people and only one…
Coming back to: What published stability data actually covers, and what it does not Replied, post #119 · Practice › Storage & stability · 21 Aug 2025 · 16 likes Practical experience of published stability data actually covers, offered as one case with the conditions stated, not as a general finding. Conditions first, because…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #71 · Evidence › Journal club · 20 Aug 2025 · 2 likes On post #67 — agreed on the reasoning, with one qualification. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone…
Enforcement priorities versus written rules — does this still hold? Started this topic · Sourcing › Regulatory · 5 Aug 2025 · 27 likes Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #13 · Analytics › COA interpretation · 30 Jul 2025 · 26 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Gauge and length selection for subcutaneous injection Replied, post #15 · Devices › Syringes & needles · 27 Jul 2025 · 0 likes Post #14 is the version of this I will quote in future. One addition. Whatever the answer on gauge and length selection turns out to be, the method for getting there is…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #38 · Sourcing › Regulatory · 30 Jun 2025 · 1 like The arithmetic in post #37 is right; the assumption feeding it is the part to check. An indication approved for one age range does not extend to another, and paediatric…
Sodium, potassium and magnesium when intake drops Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 20 Jun 2025 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Supplementing without measuring is the default approach described here and it carries its own…
Pre-registering a personal experiment, seriously Replied, post #90 · Research Methods › N-of-1 designs · 2 Jun 2025 · 1 like Post #87 answers the question as asked. The question underneath it is different. An n of one tells you about one person, which is the person you are most interested in.…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #8 · Evidence › Journal club · 16 May 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #3 · Start Here › How to Ask · 14 May 2025 · 4 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it. It is…
Ipamorelin selectivity claims and where they came from Replied, post #37 · Compounds › Secretagogues & GH axis · 13 May 2025 · 11 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #18 · Evidence › Journal club · 12 May 2025 · 11 likes Source for the STEP 4 figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper…
Excipient function in a licensed injectable Replied, post #5 · marked as the solution · Pharmacology › Formulation chemistry · 7 May 2025 · 20 likes Surfactants such as polysorbate are added to prevent adsorption and aggregation at interfaces. In a bare research preparation there is nothing performing that function.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #124 · Evidence › Journal club · 23 Apr 2025 · 10 likes Adding the boring version of STEP 1, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #59 · Practice › Reconstitution · 18 Apr 2025 · 6 likes An honest declaration on reconstituting a multi-strength kit: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
A well-designed study with a badly written abstract Replied, post #27 · Evidence › Study critique · 16 Apr 2025 · 2 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on. Two…
UK access routes, dated and sourced — a second dataset Replied, post #63 · Regional › UK & Ireland · 13 Apr 2025 · 0 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #74 · Compounds › Semaglutide · 12 Apr 2025 · 16 likes On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show. What they show is that the effect persists while…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #20 · Compounds › Secretagogues & GH axis · 6 Mar 2025 · 22 likes Building on post #17 rather than restating it. What I would want before treating Tesamorelin as settled: the method, the sample, and whether anyone tried to find the…
Reading an MS report that only gives you a single number Replied, post #21 · Analytics › Mass spectrometry · 3 Mar 2025 · 9 likes Useful. I had the fact and not the reason, which turns out to be the important half.
A supplier that answers analytical questions with restated claims Replied, post #32 · Sourcing › Red flags · 1 Mar 2025 · 15 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. That much is…
Journal club: SURMOUNT-1, read without the press release Replied, post #69 · Evidence › Journal club · 1 Mar 2025 · 26 likes Adding a small correction to the SURMOUNT-1 summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #16 · Sourcing › Regulatory · 27 Feb 2025 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. I would put the burden of proof on the…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #56 · Pharmacology › Receptor biology · 19 Feb 2025 · 0 likes Practical note on Biased agonism: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Recovery when intake is low: what to cut first Replied, post #13 · Nutrition & Training › Resistance training · 9 Jan 2025 · 24 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #46 · Practice › Interactions · 7 Jan 2025 · 6 likes Two sentences on Grapefruit and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #3 · Pharmacology › Receptor biology · 10 Dec 2024 · 0 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #63 · Access › Insurance & coverage · 10 Dec 2024 · 11 likes Post #61 and I disagree about the size of the effect, not about the direction. If someone has run Step therapy requirements properly I would rather read that than my…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #33 · Compounds › Semaglutide · 19 Nov 2024 · 0 likes Appetite effects and gastrointestinal effects are frequently reported together and are not the same mechanism reported twice. Slowed gastric emptying contributes to…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Started this topic · Evidence › Journal club · 4 Nov 2024 · 41 likes The question in the title: Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? I will give what I have already checked below so nobody repeats…
Promotion criteria, and the one that stops most nominations Replied, post #96 · Documentation › Doc review · 26 Oct 2024 · 11 likes This is the answer, and the reason it is the answer is the more useful part.
Blind submission and why it changes minds Replied, post #34 · Sourcing › Independent verification · 11 Aug 2024 · 11 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. Worth reading the earlier posts…